0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-inflammatory Therapeutics Sales Market Report 2022
Published Date: August 2022
|
Report Code: QYRE-Auto-6C11381
Home | Market Reports | Health| Health Conditions| Cancer
Global Anti inflammatory Therapeutics Sales Market Report 2022

Global Anti-inflammatory Therapeutics Sales Market Report 2022

Code: QYRE-Auto-6C11381
Report
August 2022
128 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Market Analysis and Insights: Global Anti-inflammatory Therapeutics Market

Due to the COVID-19 pandemic, the global Anti-inflammatory Therapeutics market size is estimated to be worth US$ 110540 million in 2021 and is forecast to a readjusted size of US$ 110540 million by 2028 with a CAGR of 6.1% during the review period.

Fully considering the economic change by this health crisis, by Type accounting for % of the Anti-inflammatory Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While by Type segment is altered to an % CAGR throughout this forecast period.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
Global Anti-inflammatory Therapeutics Scope and Market Size
The global Anti-inflammatory Therapeutics market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Anti-inflammatory Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

Segment by Type

Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others

Segment by Application

Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others

BY REGION

United States
Europe
China
Japan
Southeast Asia
India
Other Regions

BY COMPANY

AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-inflammatory Therapeutics Market Size by Type (2017 VS 2021VS 2028)
1.2.2 Anti-inflammatory Biologics
1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.2.4 Corticosteroids
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anti-inflammatory Therapeutics Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-inflammatory Therapeutics Market Perspective (2017-2028)
2.2 Global Anti-inflammatory Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.3 Global Anti-inflammatory Therapeutics Revenue Market Share by Region (2017-2022)
2.4 Global Anti-inflammatory Therapeutics Revenue Forecast by Region (2023-2028)
2.5 Geographic Market Analysis: Market Facts & Figures
2.5.1 United States Anti-inflammatory Therapeutics Estimates and Projections (2017-2028)
2.5.2 Europe Anti-inflammatory Therapeutics Estimates and Projections (2017-2028)
2.5.3 China Anti-inflammatory Therapeutics Estimates and Projections (2017-2028)
2.5.4 Japan Anti-inflammatory Therapeutics Estimates and Projections (2017-2028)
2.5.5 Southeast Asia Anti-inflammatory Therapeutics Estimates and Projections (2017-2028)
2.5.6 India Anti-inflammatory Therapeutics Estimates and Projections (2017-2028)
3 Global Anti-inflammatory Therapeutics Competition Landscape by Players
3.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2017-2022)
3.1.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-inflammatory Therapeutics Revenue
3.4 Global Anti-inflammatory Therapeutics Market Concentration Ratio
3.4.1 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapeutics Revenue in 2021
3.5 Anti-inflammatory Therapeutics Key Players Head office and Area Served
3.6 Key Players Anti-inflammatory Therapeutics Product Solution and Service
3.7 Date of Enter into Anti-inflammatory Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-inflammatory Therapeutics Breakdown Data by Type
4.1 Global Anti-inflammatory Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2023-2028)
5 Anti-inflammatory Therapeutics Breakdown Data by Application
5.1 Global Anti-inflammatory Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2023-2028)
6 United States Anti-inflammatory Therapeutics Market Facts & Figures
6.1 United States Anti-inflammatory Therapeutics Revenue by Company (2017-2022)
6.2 United States Anti-inflammatory Therapeutics Market Size by Type
6.2.1 United States Anti-inflammatory Therapeutics Market Size by Type (2017-2022)
6.2.2 United States Anti-inflammatory Therapeutics Market Size by Type (2023-2028)
6.2.3 United States Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
6.3 United States Anti-inflammatory Therapeutics Market Size by Application
6.3.1 United States Anti-inflammatory Therapeutics Market Size by Application (2017-2022)
6.3.2 United States Anti-inflammatory Therapeutics Market Size by Application (2023-2028)
6.3.3 United States Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
7 Europe Anti-inflammatory Therapeutics Market Facts & Figures
7.1 Europe Anti-inflammatory Therapeutics Revenue by Company (2017-2022)
7.2 Europe Anti-inflammatory Therapeutics Market Size by Type
7.2.1 Europe Anti-inflammatory Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Anti-inflammatory Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
7.3 Europe Anti-inflammatory Therapeutics Market Size by Application
7.3.1 Europe Anti-inflammatory Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Anti-inflammatory Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
8 China Anti-inflammatory Therapeutics Market Facts & Figures
8.1 China Anti-inflammatory Therapeutics Revenue by Company (2017-2022)
8.2 China Anti-inflammatory Therapeutics Market Size by Type
8.2.1 China Anti-inflammatory Therapeutics Market Size by Type (2017-2022)
8.2.2 China Anti-inflammatory Therapeutics Market Size by Type (2023-2028)
8.2.3 China Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
8.3 China Anti-inflammatory Therapeutics Market Size by Application
8.3.1 China Anti-inflammatory Therapeutics Market Size by Application (2017-2022)
8.3.2 China Anti-inflammatory Therapeutics Market Size by Application (2023-2028)
8.3.3 China Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
9 Japan Anti-inflammatory Therapeutics Market Facts & Figures
9.1 Japan Anti-inflammatory Therapeutics Revenue by Company (2017-2022)
9.2 Japan Anti-inflammatory Therapeutics Market Size by Type
9.2.1 Japan Anti-inflammatory Therapeutics Market Size by Type (2017-2022)
9.2.2 Japan Anti-inflammatory Therapeutics Market Size by Type (2023-2028)
9.2.3 Japan Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
9.3 Japan Anti-inflammatory Therapeutics Market Size by Application
9.3.1 Japan Anti-inflammatory Therapeutics Market Size by Application (2017-2022)
9.3.2 Japan Anti-inflammatory Therapeutics Market Size by Application (2023-2028)
9.3.3 Japan Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
10 Southeast Asia Anti-inflammatory Therapeutics Market Facts & Figures
10.1 Southeast Asia Anti-inflammatory Therapeutics Revenue by Company (2017-2022)
10.2 Southeast Asia Anti-inflammatory Therapeutics Market Size by Type
10.2.1 Southeast Asia Anti-inflammatory Therapeutics Market Size by Type (2017-2022)
10.2.2 Southeast Asia Anti-inflammatory Therapeutics Market Size by Type (2023-2028)
10.2.3 Southeast Asia Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
10.3 Southeast Asia Anti-inflammatory Therapeutics Market Size by Application
10.3.1 Southeast Asia Anti-inflammatory Therapeutics Market Size by Application (2017-2022)
10.3.2 Southeast Asia Anti-inflammatory Therapeutics Market Size by Application (2023-2028)
10.3.3 Southeast Asia Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
11 India Anti-inflammatory Therapeutics Market Facts & Figures
11.1 India Anti-inflammatory Therapeutics Revenue by Company (2017-2022)
11.2 India Anti-inflammatory Therapeutics Market Size by Type
11.2.1 India Anti-inflammatory Therapeutics Market Size by Type (2017-2022)
11.2.2 India Anti-inflammatory Therapeutics Market Size by Type (2023-2028)
11.2.3 India Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
11.3 India Anti-inflammatory Therapeutics Market Size by Application
11.3.1 India Anti-inflammatory Therapeutics Market Size by Application (2017-2022)
11.3.2 India Anti-inflammatory Therapeutics Market Size by Application (2023-2028)
11.3.3 India Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
12 Key Players Profiles
12.1 AbbVie
12.1.1 AbbVie Company Details
12.1.2 AbbVie Business Overview
12.1.3 AbbVie Anti-inflammatory Therapeutics Introduction
12.1.4 AbbVie Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
12.1.5 AbbVie Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Introduction
12.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
12.2.5 Johnson & Johnson Recent Development
12.3 Amgen Inc
12.3.1 Amgen Inc Company Details
12.3.2 Amgen Inc Business Overview
12.3.3 Amgen Inc Anti-inflammatory Therapeutics Introduction
12.3.4 Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
12.3.5 Amgen Inc Recent Development
12.4 AstraZeneca PLC
12.4.1 AstraZeneca PLC Company Details
12.4.2 AstraZeneca PLC Business Overview
12.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Introduction
12.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
12.4.5 AstraZeneca PLC Recent Development
12.5 Pfizer, Inc
12.5.1 Pfizer, Inc Company Details
12.5.2 Pfizer, Inc Business Overview
12.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Introduction
12.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
12.5.5 Pfizer, Inc Recent Development
12.6 Novartis
12.6.1 Novartis Company Details
12.6.2 Novartis Business Overview
12.6.3 Novartis Anti-inflammatory Therapeutics Introduction
12.6.4 Novartis Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
12.6.5 Novartis Recent Development
12.7 Roche
12.7.1 Roche Company Details
12.7.2 Roche Business Overview
12.7.3 Roche Anti-inflammatory Therapeutics Introduction
12.7.4 Roche Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
12.7.5 Roche Recent Development
12.8 Merck
12.8.1 Merck Company Details
12.8.2 Merck Business Overview
12.8.3 Merck Anti-inflammatory Therapeutics Introduction
12.8.4 Merck Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
12.8.5 Merck Recent Development
12.9 Sanofi
12.9.1 Sanofi Company Details
12.9.2 Sanofi Business Overview
12.9.3 Sanofi Anti-inflammatory Therapeutics Introduction
12.9.4 Sanofi Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
12.9.5 Sanofi Recent Development
12.10 GlaxoSmithKline
12.10.1 GlaxoSmithKline Company Details
12.10.2 GlaxoSmithKline Business Overview
12.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Introduction
12.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
12.10.5 GlaxoSmithKline Recent Development
12.11 Sun Pharmaceutical Industries Ltd
12.11.1 Sun Pharmaceutical Industries Ltd Company Details
12.11.2 Sun Pharmaceutical Industries Ltd Business Overview
12.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Introduction
12.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
12.11.5 Sun Pharmaceutical Industries Ltd Recent Development
12.12 TEVA
12.12.1 TEVA Company Details
12.12.2 TEVA Business Overview
12.12.3 TEVA Anti-inflammatory Therapeutics Introduction
12.12.4 TEVA Revenue in Anti-inflammatory Therapeutics Business (2017-2022)
12.12.5 TEVA Recent Development
13 Market Dynamics
13.1 Anti-inflammatory Therapeutics Industry Trends
13.2 Anti-inflammatory Therapeutics Market Drivers
13.3 Anti-inflammatory Therapeutics Market Challenges
13.4 Anti-inflammatory Therapeutics Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author List
15.3 Disclaimer
List of Tables
    Table 1. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (US$ Million): (2017 VS 2021 VS 2028)
    Table 2. Major Players of Anti-inflammatory Biologics
    Table 3. Major Players of Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
    Table 4. Key Players of Corticosteroids
    Table 5. Key Players of Others
    Table 6. Global Anti-inflammatory Therapeutics Market Size Growth by Application (2017 VS 2021 VS 2028)
    Table 7. Global Anti-inflammatory Therapeutics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 8. Global Anti-inflammatory Therapeutics Revenue (US$ Million) Market Share by Region (2017-2022))
    Table 9. Global Anti-inflammatory Therapeutics Revenue Share by Region (2017-2022)
    Table 10. Global Anti-inflammatory Therapeutics Revenue (US$ Million) Forecast by Region (2023-2028)
    Table 11. Global Anti-inflammatory Therapeutics Revenue Share Forecast by Region (2023-2028)
    Table 12. Global Anti-inflammatory Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 13. Global Anti-inflammatory Therapeutics Revenue Share by Players (2017-2022)
    Table 14. Global Anti-inflammatory Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Therapeutics as of 2021)
    Table 15. Ranking of Global Top Anti-inflammatory Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 16. Global 5 Largest Players Market Share by Anti-inflammatory Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 17. Key Players Headquarters and Area Served
    Table 18. Key Players Anti-inflammatory Therapeutics Product Solution and Service
    Table 19. Date of Enter into Anti-inflammatory Therapeutics Market
    Table 20. Mergers & Acquisitions, Expansion Plans
    Table 21. Global Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 22. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2017-2022)
    Table 23. Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 24. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2023-2028)
    Table 25. Global Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 26. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2017-2022)
    Table 27. Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 28. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2023-2028)
    Table 29. United States Anti-inflammatory Therapeutics Revenue by Company (2017-2022) & (US$ Million)
    Table 30. United States Anti-inflammatory Therapeutics Revenue Market Share by Company (2017-2022)
    Table 31. United States Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & ()
    Table 32. United States Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & ()
    Table 33. United States Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & ()
    Table 34. United States Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & ()
    Table 35. Europe Anti-inflammatory Therapeutics Revenue by Company (2017-2022) & (US$ Million)
    Table 36. Europe Anti-inflammatory Therapeutics Revenue Market Share by Company (2017-2022)
    Table 37. Europe Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 41. China Anti-inflammatory Therapeutics Revenue by Company (2017-2022) & (US$ Million)
    Table 42. China Anti-inflammatory Therapeutics Revenue Market Share by Company (2017-2022)
    Table 43. China Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 44. China Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 45. China Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 46. China Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Japan Anti-inflammatory Therapeutics Revenue by Company (2017-2022) & (US$ Million)
    Table 48. Japan Anti-inflammatory Therapeutics Revenue Market Share by Company (2017-2022)
    Table 49. Japan Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Japan Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Japan Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Japan Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Southeast Asia Anti-inflammatory Therapeutics Revenue by Company (2017-2022) & (US$ Million)
    Table 54. Southeast Asia Anti-inflammatory Therapeutics Revenue Market Share by Company (2017-2022)
    Table 55. Southeast Asia Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Southeast Asia Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Southeast Asia Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Southeast Asia Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 59. India Anti-inflammatory Therapeutics Revenue by Company (2017-2022) & (US$ Million)
    Table 60. India Anti-inflammatory Therapeutics Revenue Market Share by Company (2017-2022)
    Table 61. India Anti-inflammatory Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 62. India Anti-inflammatory Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 63. India Anti-inflammatory Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 64. India Anti-inflammatory Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 65. AbbVie Company Details
    Table 66. AbbVie Description and Business Overview
    Table 67. AbbVie Anti-inflammatory Therapeutics Product
    Table 68. AbbVie Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 69. AbbVie Recent Development
    Table 70. Johnson & Johnson Company Details
    Table 71. Johnson & Johnson Description and Business Overview
    Table 72. Johnson & Johnson Anti-inflammatory Therapeutics Product
    Table 73. Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 74. Johnson & Johnson Recent Development
    Table 75. Amgen Inc Company Details
    Table 76. Amgen Inc Description and Business Overview
    Table 77. Amgen Inc Anti-inflammatory Therapeutics Product
    Table 78. Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 79. Amgen Inc Recent Development
    Table 80. AstraZeneca PLC Company Details
    Table 81. AstraZeneca PLC Description and Business Overview
    Table 82. AstraZeneca PLC Anti-inflammatory Therapeutics Product
    Table 83. AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 84. AstraZeneca PLC Recent Development
    Table 85. Pfizer, Inc Company Details
    Table 86. Pfizer, Inc Description and Business Overview
    Table 87. Pfizer, Inc Anti-inflammatory Therapeutics Product
    Table 88. Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 89. Pfizer, Inc Recent Development
    Table 90. Novartis Company Details
    Table 91. Novartis Description and Business Overview
    Table 92. Novartis Anti-inflammatory Therapeutics Product
    Table 93. Novartis Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 94. Novartis Recent Development
    Table 95. Roche Company Details
    Table 96. Roche Description and Business Overview
    Table 97. Roche Anti-inflammatory Therapeutics Product
    Table 98. Roche Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 99. Roche Recent Development
    Table 100. Merck Company Details
    Table 101. Merck Anti-inflammatory Therapeutics Product
    Table 102. Merck Description and Business Overview
    Table 103. Merck Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 104. Merck Recent Development
    Table 105. Sanofi Company Details
    Table 106. Sanofi Anti-inflammatory Therapeutics Product
    Table 107. Sanofi Description and Business Overview
    Table 108. Sanofi Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 109. Sanofi Recent Development
    Table 110. GlaxoSmithKline Company Details
    Table 111. GlaxoSmithKline Description and Business Overview
    Table 112. GlaxoSmithKline Anti-inflammatory Therapeutics Product
    Table 113. GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 114. GlaxoSmithKline Recent Development
    Table 115. Sun Pharmaceutical Industries Ltd Company Details
    Table 116. Sun Pharmaceutical Industries Ltd Description and Business Overview
    Table 117. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product
    Table 118. Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 119. Sun Pharmaceutical Industries Ltd Recent Development
    Table 120. TEVA Company Details
    Table 121. TEVA Description and Business Overview
    Table 122. TEVA Anti-inflammatory Therapeutics Product
    Table 123. TEVA Revenue in Anti-inflammatory Therapeutics Business (2017-2022) & (US$ Million)
    Table 124. TEVA Recent Development
    Table 125. Anti-inflammatory Therapeutics Market Trends
    Table 126. Anti-inflammatory Therapeutics Market Drivers
    Table 127. Anti-inflammatory Therapeutics Market Challenges
    Table 128. Anti-inflammatory Therapeutics Market Restraints
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anti-inflammatory Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Anti-inflammatory Biologics Features
    Figure 3. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Features
    Figure 4. Corticosteroids Features
    Figure 5. Others Features
    Figure 6. Global Anti-inflammatory Therapeutics Market Share by Application: 2021 VS 2028
    Figure 7. Arthritis Case Studies
    Figure 8. Respiratory Diseases Case Studies
    Figure 9. Dermatology Case Studies
    Figure 10. Gastroenterology Case Studies
    Figure 11. Others Case Studies
    Figure 12. Anti-inflammatory Therapeutics Report Years Considered
    Figure 13. Global Anti-inflammatory Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Anti-inflammatory Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Anti-inflammatory Therapeutics Revenue Market Share by Region: 2017 VS 2021
    Figure 16. United States Anti-inflammatory Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
    Figure 17. Europe Anti-inflammatory Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
    Figure 18. China Anti-inflammatory Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
    Figure 19. Japan Anti-inflammatory Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
    Figure 20. Southeast Asia Anti-inflammatory Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
    Figure 21. India Anti-inflammatory Therapeutics Revenue (Million USD) Growth Rate (2017-2028)
    Figure 22. Global Anti-inflammatory Therapeutics Market Share by Players in 2021
    Figure 23. Global Top Anti-inflammatory Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapeutics as of 2021)
    Figure 24. The Top 10 and 5 Players Market Share by Anti-inflammatory Therapeutics Revenue in 2021
    Figure 25. United States Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
    Figure 26. United States Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
    Figure 27. Europe Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
    Figure 28. Europe Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
    Figure 29. China Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
    Figure 30. China Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
    Figure 31. Japan Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
    Figure 32. Japan Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
    Figure 33. Southeast Asia Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
    Figure 34. Southeast Asia Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
    Figure 35. India Anti-inflammatory Therapeutics Market Share by Type (2017-2028)
    Figure 36. India Anti-inflammatory Therapeutics Market Share by Application (2017-2028)
    Figure 37. AbbVie Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 38. Johnson & Johnson Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 39. Amgen Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 40. AstraZeneca PLC Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 41. Pfizer, Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 42. Novartis Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 43. Roche Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 44. Merck Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 45. Sanofi Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 46. GlaxoSmithKline Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 47. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 48. TEVA Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2017-2022)
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4000
This license allows only one user to access the PDF.

Electronic (PDF)
$6000
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$8000
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Add to Cart

Global Radiotherapy Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Radiotherapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-9H875
Thu Sep 22 00:00:00 UTC 2022

Add to Cart

Global Platinum based Cancer Drug Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
Global Platinum based Cancer Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-1U12322
Tue Sep 20 00:00:00 UTC 2022

Add to Cart

Global Enzymatic Debridement Market Insights Forecast to 2026
Global Enzymatic Debridement Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-11F2665
Thu Sep 15 00:00:00 UTC 2022

Add to Cart